University of Cincinnati opens blood cancer healing center

Andrew Evens named editor-in-chief of the British Journal of Haematology; Phillip Scheinberg named editor-in-chief of eJHaem

Andrew M. EvensPhillip ScheinbergThe British Journal of Haematology announced the appointment of Andrew M. Evens as its editor-in-chief, effective Jan. 1, 2025.

December 06, 2024

Vol.50 No.45

Drugs & Targets

ConcertAI and NeoGenomics announce AI software-as-a-service solution for hematology clinical research

ConcertAI announced a joint software-as-a-service solution in hematological malignancies for research analytics, clinical trial design, and clinical trial operational optimization.

December 06, 2024

Vol.50 No.45

In Brief

Thomas Bradley named director of hematology and oncology at Northwell’s Florina Cancer Center

Thomas Bradley has been appointed director of hematology and oncology at Staten Island University Hospital’s Florina Cancer Center to spearhead the division’s clinical, educational, and research initiatives.

October 25, 2024

Vol.50 No.40

In Brief

Michael Seidman joins Fox Chase Department of Hematology/Oncology

Michael Seidman has joined Fox Chase Cancer Center as a professor in the Department of Hematology/Oncology.

August 09, 2024

Vol.50 No.32

Clinical Roundup

Cell donor’s socioeconomic status shapes cancer treatment outcomes

The socioeconomic status of cell donors affects the health outcomes of blood cancer patients who underwent hematopoietic cell transplantation, according to a new study led by researchers at the University of Minnesota Medical School.

July 19, 2024

Vol.50 No.29

Conversation with The Cancer Letter

Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence

More than half of deaths that are not attributed to disease progression or recurrence after CAR T-cell therapy are caused by infections—an unprecedented finding that experts say marks a shift from a conventional focus on mitigating treatment-specific adverse events to including prevention and management of infections.

July 12, 2024

Vol.50 No.28

By Matthew Bin Han Ong

University of Cincinnati opens blood cancer healing center

YOU MAY BE INTERESTED IN

Andrew Evens named editor-in-chief of the British Journal of Haematology; Phillip Scheinberg named editor-in-chief of eJHaem

ConcertAI and NeoGenomics announce AI software-as-a-service solution for hematology clinical research

Thomas Bradley named director of hematology and oncology at Northwell’s Florina Cancer Center

Michael Seidman joins Fox Chase Department of Hematology/Oncology

Cell donor’s socioeconomic status shapes cancer treatment outcomes

Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence

Renew today!

Subscriber content

Never miss an issue!

Login

University of Cincinnati opens blood cancer healing center

YOU MAY BE INTERESTED IN

Andrew Evens named editor-in-chief of the British Journal of Haematology; Phillip Scheinberg named editor-in-chief of eJHaem

ConcertAI and NeoGenomics announce AI software-as-a-service solution for hematology clinical research

Thomas Bradley named director of hematology and oncology at Northwell’s Florina Cancer Center

Michael Seidman joins Fox Chase Department of Hematology/Oncology

Cell donor’s socioeconomic status shapes cancer treatment outcomes

Infections are a major cause of death in patients treated with CAR T-cell therapyMeta-analysis focused on causes of death, excluding relapse, recurrence

Never miss an issue!

Login

Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence